David N. Gill, Director at HISTOGENICS CORP (HSGX), bought 3,000 shares at $1.68 ($5K) on 2017-05-16, disclosed to the SEC on 2017-05-17.
Open-market purchase of $5k HSGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| YMAB | SELL | 2021-01-20 | $93K | — | Filing → |
| YMAB | SELL | 2020-11-20 | $92K | — | Filing → |
| YMAB | SELL | 2020-11-05 | $180K | — | Filing → |